Canyon Pharmaceuticals sales and marketing update

Canyon Pharmaceuticals launched Iprivask desirudin in the U.S. to prevent deep vein thrombosis (DVT) in patients undergoing hip replacement surgery. The wholesale acquisition cost (WAC) for the dire...